AposTherapy Revenue and Competitors
Estimated Revenue & Valuation
- AposTherapy's estimated annual revenue is currently $17.6M per year.
- AposTherapy's estimated revenue per employee is $234,900
- AposTherapy's total funding is $44.5M.
Employee Data
- AposTherapy has 75 Employees.
- AposTherapy grew their employee count by -9% last year.
AposTherapy's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder/Chief R&D Officer | Reveal Email/Phone |
AposTherapy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.9M | 32 | 3% | N/A | N/A |
#2 | $13.4M | 55 | 10% | N/A | N/A |
#3 | $25.4M | 94 | 11% | N/A | N/A |
#4 | $78.4M | 264 | 16% | N/A | N/A |
#5 | $9.3M | 43 | 10% | N/A | N/A |
#6 | $51.1M | 172 | 24% | N/A | N/A |
#7 | $65M | 219 | 0% | N/A | N/A |
#8 | $44.8M | 151 | 9% | N/A | N/A |
#9 | $6.7M | 31 | -11% | N/A | N/A |
#10 | $9.5M | 44 | 7% | N/A | N/A |
What Is AposTherapy?
AposTherapy is a clinically proven, FDA cleared, solution for knee and lower back painᅢᄁ¬ツᆲ¬タンwithout the need for surgery, injections, opioids or changing patientsᅢᄁ¬ツᆲ¬トᄁ daily routine. It addresses the root cause of the pain by shifting the pressure from the painful area and by re-educating the muscles for a healthier walking pattern, even when not wearing the device. The treatment results in long-lasting improved mobility, high patients satisfaction rate, and economical benefits to payers, providers, and participating practitioners. AposTherapy is adopted by prestigious healthcare organizations and has demonstrated success with 70,000 patients treated worldwide consistently achieving exceptionally high consumer satisfaction scores. AposTherapy is currently available in the US, UK, Israel and Singapore.
keywords:N/A$44.5M
Total Funding
75
Number of Employees
$17.6M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.9M | 75 | 21% | N/A |
#2 | $21.8M | 75 | -3% | N/A |
#3 | $8.5M | 75 | 19% | $24M |
#4 | $13.8M | 75 | -11% | N/A |
#5 | $9.5M | 75 | -12% | $3.1M |